IWel Health
IWel Health develops and markets advanced biosensing platform technology, including continuous glucose monitoring (CGM) technology, aimed at improving metabolic health management. Their mission is to provide easy-to-use, real-time glucose monitoring solutions for diabetes, prediabetes, weight loss, and general wellness, with a focus on innovation, clinical benefits, and accessible healthcare solutions.
Industries
Nr. of Employees
small (1-50)
Products
Wellness continuous glucose monitor (CGM)
An easy-to-use, disposable continuous glucose monitoring device that provides continuous real-time glucose readings and alerts, with mobile/smartwatch display.
Pet diabetes monitoring solution
A CGM-based solution adapted for monitoring glucose in pets to support veterinary diabetes care.
Wearable biosensing platform
A platform for biosensing applications intended to support metabolic health and to be extended for cardiovascular, renal and oncology uses.
Second-generation CGM device (European market launch activity)
An improved second-generation CGM device that has been prepared for European market filing and commercialization activities.
Wellness continuous glucose monitor (CGM)
An easy-to-use, disposable continuous glucose monitoring device that provides continuous real-time glucose readings and alerts, with mobile/smartwatch display.
Pet diabetes monitoring solution
A CGM-based solution adapted for monitoring glucose in pets to support veterinary diabetes care.
Wearable biosensing platform
A platform for biosensing applications intended to support metabolic health and to be extended for cardiovascular, renal and oncology uses.
Second-generation CGM device (European market launch activity)
An improved second-generation CGM device that has been prepared for European market filing and commercialization activities.
Services
Development of smartphone and smartwatch applications for real-time glucose display, coaching and wellness management.
Enrollment and execution of user studies to evaluate CGM devices and assess effects on metabolic health.
Engagement with external partners and investors for collaboration, licensing, or funding.
Development of smartphone and smartwatch applications for real-time glucose display, coaching and wellness management.
Enrollment and execution of user studies to evaluate CGM devices and assess effects on metabolic health.
Engagement with external partners and investors for collaboration, licensing, or funding.
Expertise Areas
- Continuous glucose monitoring
- Wearable biosensing platforms
- Digital health and mobile application development
- Metabolic health management and digital therapeutics
Key Technologies
- Continuous glucose monitoring
- Wearable biosensors
- Disposable wearable sensor design
- Mobile health applications
News & Updates
IWel Health announces addition of Michael A Friedman, MD, to its Scientific Board. Dr. Friedman is an experienced healthcare leader with a distinguished career in oncology research, regulatory strategy, and public healthcare policy.
Glutalor exhibits its iWel Mobile Glucose CGM Technology at the Virtual ADA 2020 Conference.
Glutalor Medical announces that its patent application for a dynamic blood glucose data acquiring device has been granted in October 2020, strengthening its glucose monitoring patent portfolio.
Glutalor Medical announced it has satisfied the requirements for ISO 13485 certification for its medical device and quality management systems.
IWel Health announces addition of Michael A Friedman, MD, to its Scientific Board. Dr. Friedman is an experienced healthcare leader with a distinguished career in oncology research, regulatory strategy, and public healthcare policy.
Glutalor exhibits its iWel Mobile Glucose CGM Technology at the Virtual ADA 2020 Conference.
Glutalor Medical announces that its patent application for a dynamic blood glucose data acquiring device has been granted in October 2020, strengthening its glucose monitoring patent portfolio.
Glutalor Medical announced it has satisfied the requirements for ISO 13485 certification for its medical device and quality management systems.